NASDAQ$BKYI

Bio-key International Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

BIO-key reported Q3 revenue growth driven by increased IDentity-as-a-Service cloud revenue.

BIO-key International, Inc. reported a 38% year-over-year increase in Q3 revenue, driven by growing demand for its cloud-based PortalGuard identity and access control solution and expansion of its Channel Alliance Partner program. The company is revising its full-year revenue guidance due to delays in large-scale projects in Africa.

  • Q3 revenue increased by 38% year-over-year, reaching $1.3 million, and 31% sequentially from Q2.
  • License fee revenues increased to $870k in Q3'21 from $346k in Q3'20.
  • Approximately 80% of total software and service revenue is now represented by recurring software subscription revenue.
  • The company revised its full-year 2021 revenue guidance to a range of $5.5M to $7M.

Headline financials

Total Revenue

$1.3M

Previous: $943K+37.7%
EPS (adj)

-$2.34

Previous: -$8.64+72.9%
Gross Margin

77.3%

Previous: 78.0%-0.9%
Capital Expenditures

-$37.9K

Previous: -$6.09K-521.6%
Free Cash Flow

-$7.15M

Previous: -$3.69M-93.5%
Net Income

-$1.02M

Previous: -$3.29M+68.9%
Operating Income

-$994K

Previous: -$2.2M+54.9%
Gross Profit

$1M

Previous: $732K+37.2%
Cash & Equivalents

$9.59M

Previous: $18.4M-47.9%
Total Assets

$20.7M

Previous: $24M-13.6%

Revenue & EPS history

Bio-key · Revenue · Quarterly

$1.3M

Q3 2021+37.7%vs Q3 2020
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Forward guidance

BIO-key revised its full-year 2021 revenue guidance to a range of $5.5M to $7M due to the timetable of material revenues from Africa pushed into 2022.

Tailwinds

  • Growing portfolio of high-margin, Software-as-a-Service solutions.
  • Rapidly increasing cybersecurity sector.
  • Strong capital position.
  • Talented development and sales teams.
  • Mid-point of revised revenue guidance represents 120% growth over 2020 revenue.

Headwinds

  • Timetable of material revenues from Africa pushed into 2022.
  • Revised full-year 2021 revenue guidance to a range of $5.5M to $7M; down from prior estimated range of $8-12M.
  • Company has a history of losses and limited revenue.
  • Company's ability to execute and deliver on contracts in Africa is uncertain.
  • The duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-3.5%

Avg return

Earnings day

-5.3%

Avg return

5 days after

-8.9%

Avg return

30 days after

25%

16 / 63 earnings

Positive

+15.9%

Q1 2017

Best reaction

-25.9%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.7%
Q3 2025-2.2%-4.1%-27.8%
Q1 2025-6.0%-2.5%-2.5%
Q2 2025-1.3%-3.7%-4.9%
Q4 2024-23.6%+2.4%-6.0%
Q3 2024-8.7%-16.5%-5.8%
Q2 2024-12.0%-12.0%+8.5%
Q1 2024-11.8%-10.0%+5.9%
Q4 2025-4.1%-9.5%-15.0%
Q4 2023-4.8%-13.8%-19.0%
Q3 2023-10.6%-15.8%-10.5%
Q2 2023-10.0%-10.0%-27.1%
Q1 2023+5.3%+21.5%+13.8%
Q4 2022-3.0%+8.2%-9.6%
Q3 2022-17.4%-27.1%-45.1%
Q2 2022-17.0%-22.6%-27.6%
Q1 2022-2.0%-6.0%-17.9%
Q4 2021-3.2%-6.0%-14.0%
Q3 2021-8.2%-10.8%-27.5%
Q2 2021-7.4%-5.5%+3.5%
Q1 2021+6.1%+8.4%+32.3%
Q4 2020+2.9%-0.9%-2.6%
Q3 2020-8.7%-4.4%-3.3%
Q2 2020+1.1%-1.4%-36.5%
Q4 2019-24.2%-20.7%-9.8%
Q3 2019-9.2%-12.1%+0.0%
Q2 2019+1.8%-6.8%-29.5%
Q1 2019-6.2%-16.9%-13.1%
Q4 2018-6.8%-4.8%-9.5%
Q3 2018+11.1%+9.3%+13.9%
Q2 2018-2.2%-2.2%-10.4%
Q1 2018-11.0%-1.3%-0.9%
Q4 2017-6.5%+2.0%+7.6%
Q3 2017-10.8%-6.1%-29.1%
Q2 2017-3.1%-4.3%-10.6%
Q1 2017+15.9%+22.0%+17.5%
Q4 2016-7.8%-5.1%-14.1%
Q3 2016-25.9%-7.4%-18.5%
Q2 2016+0.0%-4.2%+8.3%
Q1 2016-5.9%
Q4 2015+0.0%
Q3 2015+0.0%
Q2 2015+5.6%
Q1 2015+0.0%
Q4 2014+0.0%
Q3 2014+0.0%
Q2 2014+0.0%
Q1 2014-3.7%
Q4 2013+7.7%
Q3 2013-10.5%
Q2 2013+3.0%
Q1 2013+9.1%
Q4 2012+0.0%
Q3 2012+14.3%
Q1 2012+14.3%
Q4 2011-9.1%
Q3 2010-15.4%
Q3 2011-15.4%
Q2 2010+9.1%
Q2 2011+9.1%
Q1 2011-6.7%
Q4 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro